Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900432 · ClinicalTrials.gov registry record
Immune Response in Peripheral Blood of Patients With Colon Cancer
A clinical trial, sponsored by University of Arizona.
- Completed
- Registry status
- 67
- Enrollment target
NCT00900432 is a clinical trial that has completed, run by University of Arizona. The registered enrollment target is 67 participants.
The verdict
NCT00900432 has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 67 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in the immune system that may help kill cancer cells. PURPOSE: This laboratory study is looking at anticancer immune responses in the peripheral blood of patients with colon cancer.
Interventions
- OTHER laboratory biomarker analysis
- OTHER immunoenzyme technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2004-07 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00900432
The ClinicalTrials.gov registry entry for NCT00900432 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT00900432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00900432 about?
NCT00900432 is a clinical study titled "Immune Response in Peripheral Blood of Patients With Colon Cancer". RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in the immune system that may help kill cancer cells. PURPOSE: This laboratory study is looking at anticancer immune responses in the peripheral blood of patient...
What is the current status of trial NCT00900432?
This trial is currently completed. The enrollment target is 67 participants. The study started on 2004-07. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00900432?
The interventions under investigation include: laboratory biomarker analysis (OTHER), immunoenzyme technique (OTHER).
Who is sponsoring clinical trial NCT00900432?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.